NeurotrophinCell: Phase I started

Living Cell began an open-label, New Zealand Phase I trial to evaluate NtCell injected into the brain in 4 patients who have been diagnosed with

Read the full 255 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE